Related Experiment Videos
Wortmannin, a specific inhibitor of phosphatidylinositol-3 kinase, blocks osteoclastic bone resorption
I Nakamura1, N Takahashi, T Sasaki
1Department of Biochemistry, School of Dentistry, Showa University, Tokyo, Japan.
Abstract:
The biological role of phosphatidylinositol (PI)-3 kinase was examined in osteoclast-like multinucleated cells (OCLs) formed in co-cultures of mouse osteoblastic cells and bone marrow cells. The expression of PI-3 kinase in OCLs was confirmed by Western blot analysis. Wortmannin (WT), a specific inhibitor of PI-3 kinase, inhibited PI-3 kinase activity in OCLs both in vitro and in vivo. WT also inhibited pit-forming activity on dentine slices and disrupted a ringed structure of F-actin-containing dots (an actin ring) in OCLs in a dose-dependent manner. The inhibitory profiles of WT for pit and actin ring formation were similar to that for PI-3 kinase activity in OCLs. Electron microscopic analysis revealed that OCLs treated with WT did not form ruffled borders. Instead, numerous electron lucent vacuoles of differing sizes were found throughout the cytoplasm. These results suggest that PI-3 kinase is important in osteoclastic bone resorption.
Insights
Phosphatidylinositol 3-kinase (PI-3K) is crucial for osteoclast function. Inhibiting PI-3K with wortmannin blocks bone resorption and disrupts key cellular structures in osteoclasts.
Area of Science:
- Cell Biology
- Biochemistry
- Bone Biology
Background:
- Osteoclasts are critical for bone resorption.
- The role of phosphatidylinositol 3-kinase (PI-3K) in osteoclast biology is not fully understood.
- Osteoclast-like multinucleated cells (OCLs) provide a model for studying osteoclast function.
Purpose of the Study:
- To investigate the biological role of PI-3K in osteoclast-like multinucleated cells (OCLs).
- To determine the effect of PI-3K inhibition on osteoclastic bone resorption.
- To elucidate the impact of PI-3K on osteoclast cellular morphology and function.
Main Methods:
- Formation of OCLs from co-cultures of mouse osteoblastic and bone marrow cells.
- Confirmation of PI-3K expression in OCLs using Western blot analysis.
- Treatment of OCLs with wortmannin (WT), a specific PI-3K inhibitor, and assessment of its effects on PI-3K activity, pit formation, actin ring structure, and ruffled border formation via electron microscopy.
Main Results:
- PI-3K expression was confirmed in OCLs.
- Wortmannin significantly inhibited PI-3K activity in OCLs.
- WT dose-dependently inhibited pit-forming activity on dentine slices and disrupted the F-actin ring structure in OCLs.
- Electron microscopy showed that WT treatment prevented ruffled border formation and led to the presence of cytoplasmic vacuoles in OCLs.
Conclusions:
- PI-3K plays a significant role in osteoclastic bone resorption.
- Inhibition of PI-3K disrupts essential osteoclast functions, including ruffled border formation and bone matrix degradation.
- These findings highlight PI-3K as a potential therapeutic target for modulating bone resorption.